Therapeutic drug monitoring of old and newer anti-epileptic drugs. - Wikidata - awgldk - TriplyDB

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

http://www.wikidata.org/entity/Q35970354

about

Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring Enabling robust quantitative readout in an equipment-free model of device development Primidone inhibits TRPM3 and attenuates thermal nociception in vivo Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain.Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins Multiple anti-epileptic drug use in children with epilepsy in Mulago hospital, Uganda: a cross sectional study.A simple and cost-effective HPLC-UV method for the detection of levetiracetam in plasma/serum of patients with epilepsy.Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies Standard antiepileptic drugs fail to block epileptiform activity in rat organotypic hippocampal slice cultures.SPR imaging-based salivary diagnostics system for the detection of small molecule analytes.The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.Carbamazepine modulates the spatiotemporal activity in the dentate gyrus of rats and pharmacoresistant humans in vitro.Therapeutic drug monitoring of phenytoin in critically ill patients.An Analytical Study to Correlate Serum Levels of Levetiracetam with Clinical Course in Patients with Epilepsy State of the art in therapeutic drug monitoring.Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.Anti-epileptic effect of ifenprodil on neocortical pyramidal neurons in patients with malformations of cortical development.Changes in the Pharmacokinetics of Phenytoin in Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice.Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS.Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs.Primary afterdischarge in organotypic hippocampal slice cultures: effects of standard antiepileptic drugs.Blood-brain barrier dysfunction can contribute to pharmacoresistance of seizures.Simultaneous extraction and quantification of lamotrigine, phenobarbital, and phenytoin in human plasma and urine samples using solidified floating organic drop microextraction and high-performance liquid chromatography.Effect of antiepileptic drug comedication on lamotrigine concentrations.Monographs on drugs which are frequently analyzed in therapeutic drug monitoring / Arzneimittel-Monographien für Medikamente, die regelmäßig im Rahmen des Therapeutic Drug Monitorings analysiert werden Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy

P2860

Q26849557-B2BDD9E8-B9FC-4433-9475-5AA8E8DFC11E Q27024074-E0108B84-E566-4535-BCBC-6E431962D059 Q28395615-5CBF6FC9-97C4-47BE-8DFE-1C665F761F9A Q30846820-F5491C47-D65D-48E9-8EC8-DA5D55D3AE96 Q33646252-D1EE29EF-9CD6-46F2-941D-356233F17B29 Q33968508-28432CF3-12E7-44F9-9B83-75AC75B4AF04 Q33996679-C4A5DCF4-56D6-422D-AC54-273CCA0AACDE Q34649187-4A90D1DD-7461-4483-869C-F870B73DC158 Q35014028-B5EF4882-9545-4D03-A63D-24DAA24C7908 Q35094603-C0598DB7-B164-422D-BD26-705E04625C28 Q35951765-C9D47027-B813-43F5-9374-E9C758E3307B Q36308262-84786B8C-4BF8-4F09-8276-7516991171E1 Q36537180-04C374EE-6C1C-4C99-A47C-66A32AC3445F Q36736095-5728D0D2-0B76-4887-A6BC-31CCA69A9930 Q36792265-AC49118E-9959-4652-B988-78FF81E7348B Q36794851-9925C2F1-E6C4-4F85-B3DE-21F4DD1A6307 Q36805832-3613C5C9-ED6F-4147-AD3D-7DC5235528E9 Q37310486-75FA8990-E08A-4A94-9DBA-FC85A8CD27C5 Q37593001-8989BBD1-B970-42FC-A7CD-48BB4586ACD7 Q37699413-683EC9FB-DB03-4440-8953-EA5C3A30FD22 Q37875183-83D87AB3-E724-4261-8BF8-3168B71DFF45 Q39233929-705802FF-DE64-470D-B6C9-DA04AD934FFF Q39393959-E927024A-6101-460B-94E5-A622344D9D4F Q39818989-04DEE0C0-87C8-445E-BC16-185AF7117CDA Q41380075-9EEBE332-7B78-41E0-9CFE-53DFC9E9B105 Q44829751-E7320EFF-A430-473C-B2DB-D1B7AAB761D3 Q47103192-2F709C3C-487C-462A-99D3-03B15BD8CC42 Q47410358-CEF5FCB0-7547-4803-AD22-016DF51B5C94 Q47635280-3A672F08-3F61-44DC-98D9-24F79CB8FA79 Q47786666-733771F0-CAEE-44D8-A799-C8E1E780C15C Q48145585-8CAB7168-84E2-4380-A78A-62C2E8830C62 Q48676641-DDE9702B-70FF-4991-819E-AFE0B5871716 Q53513731-4D6F57B8-1B4A-423E-8E06-3216250BADC6 Q54944130-4361AB96-9832-40CC-8551-10DD852DA64D Q57550210-BEAF7EA1-3AE3-454F-A9E9-C9B8EE77AE01 Q57770173-A67315D1-368A-4813-9583-23D8F6E8D947

P2860

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

http://www.wikidata.org/entity/Q35970354

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@ast

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@en

type

label

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@ast

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@en

prefLabel

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@ast

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

@en

P1433

Q35970354-3A2B7216-946E-4995-9B01-73DEA0D3253D

P1476

Q35970354-AAC9501B-11C7-41C6-AE51-DD4F84AD060D

P2093

Q35970354-65E2FE33-58A3-401C-AD3D-8CC02EB35C08

Q35970354-7736DDAE-FAD9-407A-89BF-308C9A935230

Q35970354-7A5EDF62-5DC0-4B6A-AC66-59DB49F069BD

Q35970354-CF78D35C-0842-4C33-BE8E-2A42D9139EBC

Q35970354-EF1C7EB0-A2EC-48B2-8E00-345B898370C0

P2860

Q35970354-001E8E0E-BB3E-494A-AF94-53109DC183CD

Q35970354-01046CA1-7C8A-4333-84B2-21C3588679C2

Q35970354-057E70EE-64B2-4A6D-A86F-D29B5B41711D

Q35970354-05C89634-878D-48B0-A432-48CECCC8AE35

Q35970354-0742C13F-FC01-4220-993A-86374CF9556C

Q35970354-08C8123C-2492-42C5-B57E-D765A6AF6222

Q35970354-0BF182EF-6D11-415E-9677-2D2B240F1090

Q35970354-10228703-7FDF-4147-97E8-FFA3ED76DB09

Q35970354-12F74499-FC35-48CE-87E1-FAE053329878

Q35970354-171594EA-422C-4AE9-9F79-6865A2D59C32

P304

Q35970354-E8FBBF98-3D80-4E56-A50B-FDF52AF7B0C1

P31

Q35970354-E002AC3D-D3C8-4003-ABEA-F3E57D03BA5E

P356

Q35970354-59A9C33D-885E-41F0-B899-F69AAAC146B1

P433

Q35970354-052EFF95-40E9-40FF-81B8-BDE82AC415FA

P478

Q35970354-82A93D72-34CA-4B9D-B343-AEAB438A6504

P50

Q35970354-67FEDC5A-707C-4E6F-92FC-85DAF8D896A4

P577

Q35970354-FF522278-5215-4674-AA10-9FCF39F3EDA0

P698

Q35970354-23A9024D-155B-4058-BB8A-35CD4C907108

P356

P1433

Clinical Chemistry and Laboratory Medicine

P1476

Therapeutic drug monitoring of old and newer anti-epileptic drugs

@en

P2093

Ann C Sierens

http://www.w3.org/2001/XMLSchema#string

George M Hatfield

http://www.w3.org/2001/XMLSchema#string

Kristine Naelaerts

http://www.w3.org/2001/XMLSchema#string

Simon L Scharpé

http://www.w3.org/2001/XMLSchema#string

Willy E Lambert

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors

Valproate-induced coma with ketosis and carnitine insufficiency

Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital

Discontinuation of clonazepam after long-term treatment

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

Valproic acid hepatic fatalities. II. US experience since 1984.

Determination of benzodiazepines in human hair by on-line high-performance liquid chromatography using a restricted access extraction column.

Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography.

Selectivity of substance identification by HPLC-DAD in toxicological analysis using a UV spectra library of 2682 compounds.

Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication.

P304

1228-1255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2004.245

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15576287

http://www.w3.org/2001/XMLSchema#string